End Taxpayer Funding of Gender Experimentation Act of 2025
Summary
What This Bill Does
The bill adds new Chapter 4 to Title 1 US Code prohibiting federal funds for gender transition procedures, prohibits federal funds and federal trust funds from being expended for any gender transition procedures, and prohibits federal funds and trust funds from being expended for health benefits coverage that includes coverage of gender transition procedures. It relies on compliance mandates, exemptions, definition changes, and tax credits. The main policy areas are Healthcare and Finance.
Who Benefits and How
Healthcare providers treating disorders of sex development would be affected, Federal Treasury (reduced tax credit outlays) could see lower costs, and Private insurers offering non-federal coverage could gain revenue opportunities.
Who Bears the Burden and How
Transgender individuals seeking federally-funded care could face higher costs, Transgender individuals could face higher costs, and ACA marketplace enrollees seeking gender transition coverage could face higher costs.
Key Provisions
- Adds new Chapter 4 to Title 1 US Code prohibiting federal funds for gender transition procedures.
- Prohibits federal funds and federal trust funds from being expended for any gender transition procedures.
- Prohibits federal funds and trust funds from being expended for health benefits coverage that includes coverage of gender transition procedures.
- Prohibits gender transition services from being furnished by federal healthcare facilities or by physicians/individuals employed by the federal government.
- Exempts savings clause allowing individuals, entities, states, or localities to purchase separate coverage for gender transition using only non-federal funds, excluding Medicaid matching funds.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
The bill adds new Chapter 4 to Title 1 US Code prohibiting federal funds for gender transition procedures, prohibits federal funds and federal trust funds from being expended for any gender transition procedures, and prohibits federal funds and trust funds from being expended for health benefits coverage that includes coverage of gender transition procedures.
Key Policy Areas
Healthcare, Finance
Primary Purpose
The bill adds new Chapter 4 to Title 1 US Code prohibiting federal funds for gender transition procedures, prohibits federal funds and federal trust funds from being expended for any gender transition procedures, and prohibits federal funds and trust funds from being expended for health benefits coverage that includes coverage of gender transition procedures.
Policy Domains
Title I - Prohibition on Taxpayer-Funded Gender Transition Procedures
Identified Gains
- Healthcare providers treating disorders of sex development
- Federal Treasury (reduced tax credit outlays)
- Private insurers offering non-federal coverage
Identified Costs
- Transgender individuals seeking federally-funded care
- Transgender individuals
- ACA marketplace enrollees seeking gender transition coverage
- Veterans and military members seeking care
- VA Medical Centers
Sponsors
Legislative Progress
In CommitteeMr. Marshall (for himself, Mrs. Hyde-Smith, Mr. Cramer, Mr. Hawley, …
Read twice and referred to the Committee on Finance.
Introduced in Senate
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
ACA marketplace enrollees seeking gender transition coverage, Federal employees and military personnel, General public
Federal employee health benefit plans, Health insurers offering ACA plans with transgender coverage, Medicaid managed care plans
Positive-direction: Private insurers offering non-federal coverage
Negative-direction: Federal employee health benefit plans, Health insurers offering ACA plans with transgender coverage, Medicaid managed care plans, TRICARE military health plans
Federal healthcare facilities (VA, military), Gender transition surgery centers, Indian Health Service facilities
Endocrinologists prescribing puberty blockers, Gender transition healthcare providers, Healthcare providers treating disorders of sex development
Positive-direction: Healthcare providers treating disorders of sex development
Negative-direction: Endocrinologists prescribing puberty blockers, Gender transition healthcare providers, Plastic surgeons performing gender-affirming procedures
States contracting for private coverage, States offering gender transition coverage with state-only funds
Federal Treasury (reduced tax credit outlays), US Code editors
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
Key Definitions
Terms defined in this bill
Services for disorders of sex development and treatment for infection, injury, disease or disorder caused by prior gender transition procedures are excluded
An individual who naturally has, had, will have, or would have the reproductive system that produces, transports, and utilizes eggs for fertilization
The process in which an individual goes from identifying with or presenting as his or her sex to identifying with or presenting a self-proclaimed identity that does not correspond with his or her sex
Any hormonal or surgical intervention for the purpose of gender transition, including puberty blockers, cross-sex hormones, and over 30 enumerated surgical procedures
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology